SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Aventura, FL.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantir is seeing intense speculation and polarized debate as investors brace for upcoming earnings, with the community closely tracking indicators of AI-driven commercial demand and sovereign contract growth. Market participants are split between bullish sentiment fueled by potential revenue acceleration and skeptical outlooks regarding the stock's premium valuation and the sustainability of its AI-related expansion.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is trending following the announcement of a private exchange of debt for equity, a move that has sparked intense debate among investors regarding the balance between long-term debt reduction and immediate shareholder dilution. The community remains deeply divided, with some viewing the move as a strategic cleanup of the balance sheet ahead of potential acquisitions, while others express frustration over the impact on share price and management's capital allocation decisions.

Snap, Inc. is a technology company, which engages in the provision of a visual messaging application that was created to help people communicate through short videos and images. The company was founded by Frank Reginald Brown IV, Evan Thomas Spiegel, and Robert C. Murphy in 2010 and is headquartered in Santa Monica, CA.

Snap Inc - Ordinary Shares - Class A

Snap Inc

Snap is currently trending as retail investors and traders speculate on a potential volatility breakout ahead of the company's earnings release, with heavy call option activity highlighting both high-stakes bets and deep skepticism regarding leadership's execution. Discussion remains polarized between those anticipating a major turnaround driven by AI-integrated hardware and ad revenue recovery, and others frustrated by the stock's long-term performance and the company's complex governance structure.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

The community is closely monitoring the anticipated 80th event data release and potential buyout rumors, as recent volatility and speculation about clinical progress fuel intense debate between long-term bulls and skeptical short-sellers. Investors are focused on imminent trial readouts and are actively analyzing institutional ownership shifts, hoping for a significant catalyst to break the stock out of its current consolidation range.

Celsius Holdings, Inc. engages in the development, marketing, sale, and distribution of functional drinks and liquid supplements. It also offers post-workout functional energy drinks and protein bars. The company was founded in April 2004 and is headquartered in Boca Raton, FL.

Celsius Holdings Inc

Celsius is facing intense volatility as investors weigh robust long-term brand growth and market share gains against concerns regarding margin compression, aggressive short selling, and sector-wide rotation. The community is sharply divided, with bulls viewing the current depressed price as a generational buying opportunity ahead of upcoming earnings, while bears point to heightened competition and technical weakness as indicators of further downside.

Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was founded by Philip Astley-Sparke, Colin A. Love, and Robert Coffin in March 2015 and is headquartered in Woburn, MA.

Replimune Group Inc

Replimune Group Inc is trending after an FDA advisory committee voted 10-3 to support the efficacy of its lead cancer therapy, triggering significant bullish sentiment among retail traders who are now anticipating a potential short squeeze. The community remains divided between investors celebrating a major regulatory hurdle cleared and skeptics who highlight the company's precarious cash position and potential for future equity dilution.

Luckin Coffee, Inc. engages in providing food and beverage items, and operates coffee retail stores. It has a pioneered a technology-driven retail network to provide coffee and other products of high quality, high convenience and high affordability to customers. The company manages pick-up stores, relax stores, and delivery kitchens. It also offers tea, snacks, and light meals through its mobile application. The company was founded by Zhi Ya Qian, Fei Yang and Jin Yi Guo on June 16, 2017 and is headquartered in Xiamen, China.

Luckin Coffee Inc - ADR

Investors are actively debating Luckin Coffee's long-term growth potential and store expansion strategy in the U.S. and China, while closely monitoring upcoming earnings reports for catalysts that could trigger a price breakout. Sentiment remains polarized between long-term holders confident in the company's fundamentals and those concerned about market volatility, OTC listing status, and the ongoing competitive landscape.

Spotify Technology SA engages in the provision of digital music services. It operates through the Premium and Ad-Supported segments. The Premium segment provides subscribers with online and offline streaming access of music and podcasts on computers, tablets, and mobile devices. The Ad-Supported segment offers users with limited on-demand online access of music and unlimited online access of podcasts on computers, tablets, and mobile and smart devices. The company was founded by Daniel Ek and Martin Lorentzon on December 27, 2006 and is headquartered in Luxembourg.

Spotify Technology S.A.

Spotify is generating significant market activity as investors weigh bullish institutional analyst upgrades and positive long-term outlooks against the stock's recent volatility. The community remains focused on potential AI-driven monetization, subscriber growth trends, and the upcoming investor day as key catalysts for future movement.

Blue Owl Capital, Inc. operates as an alternative asset management firm. It provides investors access to asset management capital solutions through its Direct Lending and GP Capital Solutions products. The company offers a platform of capital solutions to both middle market companies and large alternative asset managers. The company was founded by Doug Irving Ostrover, Michael Rees and Craig W.Packer in 2009 and is headquartered in New York, NY.

Blue Owl Capital Inc - Ordinary Shares - Class A

Blue Owl Capital is trending as investors debate the impact of redemption requests and private credit sector volatility, with community members closely watching institutional buying patterns and recent bond market activity. Sentiment remains split between those viewing the current valuation as a significant discount and others expressing caution regarding potential liquidity constraints in the sector.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TG Therapeutics is experiencing a significant sell-off following an earnings release that, while beating revenue expectations and raising full-year guidance, resulted in an EPS miss driven by reinvestment in clinical pipeline growth. Shareholders are currently debating whether the sharp price decline represents a manufactured short attack or a standard market reaction to earnings-related volatility, with many long-term investors highlighting strong commercial execution and the potential for a future acquisition as reasons to maintain their positions.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

It’s Not Too Late to Make Money Investing in This Gold ETF 
With the price of gold futures stabilising at around the $2,630 – $2,650 per ounce mark, cooling -4.56% from the all time high prices reached at the end of October. This could very well be the opportunity investors have long been waiting for to make their entry into gold markets. The next few months will be critical for gold. Analysts expect gold to surge next year, providing an opportunity for handsome gains in 2025. 
 
Impressive YTD Returns For GOLY ETF Investors 
 
Strategy Shares Gold ETF (Ticker: $GOLY) has already provided its investors with an impressive 22.85% YTD return (as of 12/06/24), placing it firmly in the top 1% of funds in its category according to Morning Star. What helped GOLY secure those returns was combining the returns from the price appreciation of gold over the last year with a distribution paid to its investors monthly, amounting to 5.1% annually. This makes Strategy Shares&#39; GOLY a great product for investors

StockTwits Web

Strategy Shares - Strategy Shares Gold-Hedged Bond ETF

It’s Not Too Late to Make Money Investing in This Gold ETF 
With the price of gold futures stabilising at around the $2,630 – $2,650 per ounce mark, cooling -4.56% from the all time high prices reached at the end of October. This could very well be the opportunity investors have long been waiting for to make their entry into gold markets. The next few months will be critical for gold. Analysts expect gold to surge next year, providing an opportunity for handsome gains in 2025. 
 
Impressive YTD Returns For GOLY ETF Investors 
 
Strategy Shares Gold ETF (Ticker: 

) has already provided its investors with an impressive 22.85% YTD return (as of 12/06/24), placing it firmly in the top 1% of funds in its category according to Morning Star. What helped GOLY secure those returns was combining the returns from the price appreciation of gold over the last year with a distribution paid to its investors monthly, amounting to 5.1% annually. This makes Strategy Shares' GOLY a great product for investors